A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Clinical trial NCT06588686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06588686
- Sponsor
- Vicore Pharma AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2027-05-01
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.